Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

This study has been completed.
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI) Identifier:
First received: May 25, 2000
Last updated: February 17, 2016
Last verified: January 2008
To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. The four cohorts include the Chicago Heart Association Detection Project in Industry cohort, the Peoples Gas Company cohort first examined in 1958-1959, the Peoples Gas Company cohort first examined in 1959-1962, and the Western Electric Company cohort.

Cardiovascular Diseases
Heart Diseases
Coronary Disease
Cerebrovascular Disorders
Diabetes Mellitus
Cerebrovascular Accident

Study Type: Observational

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: September 1977
Study Completion Date: July 2006
Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
  Show Detailed Description


Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
No eligibility criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00005140

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
OverallOfficial: Philip Greenland Northwestern University
  More Information

Stamler J, Stamler R, Liu K: High Blood Pressure: Role in Coronay Heart Disease, and Implications for Prevention and Control. In: Connor WE, Bristow DJ (Eds), Coronary Heart Disease - Prevention, Complications, and Treatment, Lippincott, Philadelphia, Pa, p 85-109, 1985
Stamler J, Farinaro E, Riccardi G, Stamler R, Mancini M: Does asymptomatic Hyperglycemia Always Have to be Treated? (Italian), J Ital Diabetol, 3:1-7, 1983
Kaplan NM, Stamler J (Eds): Prevention of Coronary Heart Disease--Practical Management of the Risk Factors, WB Saunders, Philadelphia, 1983
Stamler J, Liu K: The Benefits of Prevention. In: Kaplan NM, Stamler J (Eds), Prevention of Coronary Heart Disease--Practical Management of the Risk Factors, WB Saunders, Philadelphia, pp 188-207, 1983
Stamler R, Stamler J: 'Mild' Hypertension: Risks and Strategy. Parts I and II. Primary Cardiol, 9(10):150-166, Oct, and 9(11):12-25, Nov, 1983
Stamler J, Stamler R, Liu K: High Blood Pressure: Role in Coronary Heart Disease, and Implications for Prevention and Control. Position Paper Prepared at the Request of the Non-Communicable Disease Division, and the Cardiovascular Section, World Health Organization, Geneva, Switzerland, WHO/CVD/83.5, 8th August, 1983
Stamler J: Does Cholesterol Change Alter Coronary Artery Disease Risk? Epidemiological Evidence. Proceedings of a Symposium on the Decline in Coronary Heart Disease Mortality--the Role of Cholesterol Change. Science and Medicine, New York, pp 27-45, 1983
Shekelle RB, Paul O, Stamler J: Coffee and Cholesterol. Letter to the Editor. N Engl J Med, 309:1248-1249, 1983
Stamler J: The Prevention of Coronary Heart Disease (CHD). 1. Scientific Foundations--Recent Data. European Conference on Primary Prevention of Coronary Heart Disease, Anacapri, 15-19 October 1984. World Health Organization, Geneva, Switzerland. ICP/NCD 001/15, 15 October 1984
Stamler J: The Central and Essential Role of Nutrition in the Primary and Secondary Prevention of Coronary Heart Disease and Hypertension. In: Lovenberg W, Yamori Y, (Eds), Nutritional Prevention of Cardiovascular Disease, Academic Press, New York, NY, pp 383-405, 1984
Stamler J, Stamler R, Liu K: High Blood Pressure. In: Connor WE, Bristow D (Eds), Coronary Heart Disease--Prevention, Complications, and Treatment, JB Lippincott, Philadelphia, Pa, pp 85-109, 1985
Shekelle RB, Paul O, Shryock A, Stamler J: Fish Consumption and Mortality from Coronary Heart Disease. Letter to the Editor. N Engl J Med, 313:820, 1985
Stamler J, Giumetti D, Liu K, Stamler R, Dyer A: The Risks of Hypertension. Proceedings of the Symposium on Control of Arterial Hypertension in the Prevention of Cardiovascular Disease, Hohenreid, Federal Republic of Germany, 1986.
Liu K: Statistical Issues Related to Design of Dietary Survey Methodology for NHANES III. Proceedings of the NHANES III Dietary Survey Methodology Workshop, National Center for Health Statistics, Hyattsville, Maryland, 1992.
Stamler J: The Mass Treatment of Hypertensive Disease: Defining the Problem. In: Perry HM Jr, Smith WM, (Eds), Mild Hypertension: To Treat or Not to Treat. Ann NY Acad Sci, 304:333, 1978
Stamler J: Improving Life Styles to Control the Coronary Epidemic. Proceedings of the International Conference on Nutrition, Dietetics and Sport. Edizioni Minerva Medica, Torino, p 5, 1978
Stamler J: Clinical Problems in Hypertension #2. A Patient with Mild Hypertension. A Taped Presentation. Health Learning Systems, Inc, Bloomfield NJ, 1978
Stamler J: Epidemiology and Treatment of Hypertension. In: Carlson RJ, Cunningham R, (Eds), Future Directions in Health Care: A New Public Policy, Ballinger Publishing Co, Cambridge, MA, p 95, 1978
Stamler J: Population Studies. In: Levy RI, Rifkind BM, Dennis BH, Ernst ND, (Eds), Nutrition, Lipids, and Coronary Heart Disease--A Global View, Raven Press, New York, p 25, 1979
Stamler J: Overweight, Hypertension, Hypercholesterolemia and Coronary Heart Disease. In: Mancini M, (Ed), Medical Complications of Obesity, Proceedings of an International Conference, Naples, Italy, June 1978, Academic Press, London, 191-216, 1979
Stamler J: Should Hyperglycemia Always be Treated? In: Mancini M, (Ed), Diet and Drugs in the Treatment of Maturity-Onset Diabetes, Proceedings of a Symposium, Naples, Italy, 28 June 1979
Stamler J: Hypertension: Aspects of Risk. In: Hunt JC, Cooper T, Frohlich ED, Gifford RW Jr, Kaplan NM, Laragh JH, Maxwell MH, Strong CG (Eds), Hypertension Update: Mechanisms, Epidemiology, Evaluation, Management, Health Learning Systems, Inc, Bloomfield, NJ, pp 23-37, 1979
Stamler J: Can An Effective Fat-Modified Diet Be Safely Recommended After Weaning for Infants and Children in General: D. General Discussion. In: Lauer RM, Shekelle RB (Eds), Childhood Prevention of Atherosclerosis and Hypertension, Raven Press, New York, pp 407-410, 1980
Stamler J: Asymptomatic Hyperglycemia and Risk of Coronary Heart Disease in Middle-Aged Men: American and International Experience. Proceedings, Diabetes and Atherosclerosis Workshop, Dallas, Texas, March 27-29, 1980
Stamler J: Data Base on the Major Cardiovascular Diseases in the United States. In: Hegyeli R (Ed), Measurement and Control of Cardiovascular Risk Factors, Atherosclerosis Reviews, Vol. 7, Raven Press, New York, pp 49-96, 1980
Berkson DM, Stamler J: Epidemiology of the Killer Chronic Diseases. In: Winick M (Ed), Nutrition and the Killer Disease, John Wiley and Sons, Inc, New York, pp 17-55, 1981
Stamler J: Improved Life Styles: Their Potential for the Primary Prevention of Atherosclerosis and Hypertension in Childhood. In: Childhood Prevention of Atherosclerosis and Hypertension, Raven Press, New York, 1980
Stamler J, Stamler R: Maturity-Onset Diabetes and Asymptomatic Hyperglycemia. Diabetes and Atherosclerosis Workshop, Sponsored by the Juvenile Diabetes Foundation and the National Heart, Lung, and Blood Institute, Dallas TX, March 27-29, 1980, Juvenile Diabetes Foundation, New York, pp 17-43, 1981
Shekelle RB, Paul O, Shryock AM, Stamler J: Dietary Lipids, Serum Cholesterol Concentration, and Risk of Death from Coronary Heart Disease. In: Noseda G, Fragiacomo C, Fumagalli R, Paoletti R (Eds). Lipoproteins and Coronary Atherosclerosis, Elsevier Biomedical Press BV, Amsterdam, pp 87-94, 1982 Identifier: NCT00005140     History of Changes
Other Study ID Numbers: 1011
R01HL021010 ( US NIH Grant/Contract Award Number )
Study First Received: May 25, 2000
Last Updated: February 17, 2016

Additional relevant MeSH terms:
Diabetes Mellitus
Cardiovascular Diseases
Heart Diseases
Coronary Disease
Coronary Artery Disease
Cerebrovascular Disorders
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Myocardial Ischemia
Vascular Diseases
Arterial Occlusive Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases processed this record on May 25, 2017